THERAVANCE BIOPHARMA INC
TBPHNASDAQ🏆 #2560 by market capEarnings Nov 9US Equity
$17.03▲ $0.00 (+0.00%)
Market closed · at closeTrack TBPH
Get earnings, price moves & breaking news on Telegram
24h▲ 0.0%
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$883M
Small Cap
📈Revenue Growth (YoY)
+35.1%
High Growth
📊Gross Margin
100.0%
High
💵FCF Margin
269.7%
Strong
⚖️P/S Ratio
8.5x
Elevated
Otter Score
64
Fair
THERAVANCE BIOPHARMA INC
TBPHAnalyst Ratings
Price
$17.03
Total
17
Raised
2
Lowered
8
Avg PT
$17.00
H / L
$17 / $17
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
HC Wainwright & Co. | Downgraded | Buy → Neutral | 2026-07-07 | — | — |
Jones Trading | Downgraded | Buy → Hold | 2026-06-29 | — | — |
BTIG | Downgraded | Buy → Neutral | 2026-06-29 | $40.00 | +134.90% |
B. Riley Securities | Reiterated | Neutral | 2026-04-07 | — | — |
TD Cowen | Reiterated | Hold | 2026-03-23 | — | — |
Oppenheimer | Downgraded | Outperform → Perform | 2026-03-05 | $27.00 | +58.50% |
Leerink Partners | Downgraded | Outperform → Market Perform | 2024-08-06 | $10.00 | −41.30% |
SVB Leerink | Reiterated | Outperform | 2022-11-17 | — | — |
Morgan Stanley | Reiterated | Underweight | 2022-07-25 | — | — |
JP Morgan | Upgraded | Underweight → Neutral | 2021-11-05 | — | — |
Cowen & Co. | Downgraded | Outperform → Market Perform | 2021-08-24 | — | — |
Needham | Reiterated | Buy | 2021-08-24 | — | — |
Piper Sandler | Reiterated | Overweight | 2020-08-10 | — | — |
Baird | Upgraded | Underperform → Neutral | 2019-11-06 | — | — |
Leerink Swann | Reiterated | Outperform | 2018-02-08 | — | — |
Bank of America | Downgraded | Neutral → Underperform | 2016-08-03 | — | — |
B of A Securities | Downgraded | Neutral → Underperform | 2016-08-03 | — | — |
Institution
HC Wainwright & Co.
Downgraded · Buy → Neutral · 2026-07-07
—
—
Jones Trading
Downgraded · Buy → Hold · 2026-06-29
—
—
BTIG
Downgraded · Buy → Neutral · 2026-06-29
$40.00
+134.90%
B. Riley Securities
Reiterated · Neutral · 2026-04-07
—
—
TD Cowen
Reiterated · Hold · 2026-03-23
—
—
Oppenheimer
Downgraded · Outperform → Perform · 2026-03-05
$27.00
+58.50%
Leerink Partners
Downgraded · Outperform → Market Perform · 2024-08-06
$10.00
−41.30%
SVB Leerink
Reiterated · Outperform · 2022-11-17
—
—
Morgan Stanley
Reiterated · Underweight · 2022-07-25
—
—
JP Morgan
Upgraded · Underweight → Neutral · 2021-11-05
—
—
Cowen & Co.
Downgraded · Outperform → Market Perform · 2021-08-24
—
—
Needham
Reiterated · Buy · 2021-08-24
—
—
Piper Sandler
Reiterated · Overweight · 2020-08-10
—
—
Baird
Upgraded · Underperform → Neutral · 2019-11-06
—
—
Leerink Swann
Reiterated · Outperform · 2018-02-08
—
—
Bank of America
Downgraded · Neutral → Underperform · 2016-08-03
—
—
B of A Securities
Downgraded · Neutral → Underperform · 2016-08-03
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space